S
Supernus Pharmaceuticals (SUPN)
$000.00 0.00% ($0.00)
- Today
- Week
- Month
- Year
- 5 Year
- YTD
getbaraka.com
About Supernus Pharmaceuticals (SUPN)
Supernus Pharmaceuticals, Inc. is a pharmaceutical company focused on developing and commercializing products for the treatment of central nervous system diseases. The Company offers Oxtellar XR (extended-release oxcarbazepine) and Trokendi XR (exten... Read more
- USD29.46
- USD30.19
- USD29.17
- USD38.09
- -7.40%
- 608M
- 330.64k
- 344.69k
- 1.6B
- 21.99
- -18.20%
- 18.40%
Stock News
1 hour ago
AI Boom’s Secret Winners? The Companies Expected to Power It
Yahoo
2 hours ago
Gilead Sciences First Quarter 2024 Earnings: Revenues Beat Expectations, EPS Lags
Yahoo
2 hours ago
Should You Investigate Keysight Technologies, Inc. (NYSE:KEYS) At US$149?
Yahoo
2 hours ago
Meta Platforms Stock Just Plunged. Should You Buy the Dip or Run for Cover?
Yahoo
Unlock More Stock Analysis & Reports
Access detailed stock analysis from LSEG including analyst price target estimates.
